Hume David A, Fairlie David P
Institute for Molecular Bioscience, University of Queensland, Brisbane, Qld 4072, Australia.
Curr Med Chem. 2005;12(25):2925-9. doi: 10.2174/092986705774462923.
This commentary is an introduction to a special issue on "Latest Developments in the Treatment of Inflammation". It outlines some key events in the inflammatory response to infection or injury and describes some of the important drug targets of relevance to the succeeding articles, which survey inhibitors of these targets as prospective or current antiinflammatory drugs. It also highlights important limitations in the validation of inflammatory drug targets, and in the rate of discovery and development of new antiinflammatory drugs.
本评论是关于“炎症治疗的最新进展”特刊的引言。它概述了对感染或损伤的炎症反应中的一些关键事件,并描述了与后续文章相关的一些重要药物靶点,这些文章将这些靶点的抑制剂作为潜在或当前的抗炎药物进行了综述。它还强调了炎症药物靶点验证以及新抗炎药物发现和开发速度方面的重要局限性。